PARK7 and endometrioid adenocarcinoma: We did not confirm results of the study published by Di Cello et al. that demonstrated significantly higher DJ1 levels (p ≤ 0.05) in patients with a high-risk histological type (endometrioid carcinoma grade 3 or non-endometrioid carcinoma) than in patients with a low-risk histotype (endometrioid carcinoma grade 1 or 2) [15].